Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial
Mayo Clinic
Mayo Clinic
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Janssen Research & Development, LLC
Case Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Milton S. Hershey Medical Center
Hackensack Meridian Health
Center for International Blood and Marrow Transplant Research
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Center for International Blood and Marrow Transplant Research
Washington University School of Medicine
Thomas Jefferson University
City of Hope Medical Center
University of Illinois at Chicago
Masonic Cancer Center, University of Minnesota
Washington University School of Medicine
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
M.D. Anderson Cancer Center
City of Hope Medical Center
City of Hope Medical Center
Thomas Jefferson University
Thomas Jefferson University
Fred Hutchinson Cancer Center
University of Alabama at Birmingham
University of California, San Diego
Weill Medical College of Cornell University
Thomas Jefferson University
St. Jude Children's Research Hospital
St. Petersburg State Pavlov Medical University
M.D. Anderson Cancer Center
City of Hope Medical Center
City of Hope Medical Center
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
City of Hope Medical Center
Thomas Jefferson University
Thomas Jefferson University
Thomas Jefferson University
Thomas Jefferson University